PMID: 6413405Sep 1, 1983Paper

Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat

Hypertension
K H BerecekS Oparil

Abstract

Previous studies from our laboratory have shown that chronic intracerebroventricular administration of captopril attenuates the development of hypertension in the spontaneously hypertensive rat of the Okamoto strain (SHR) without altering sodium and water balance, plasma renin, or sympathoadrenal activities. To determine whether the depressor effect of intracerebroventricular captopril was associated with an alteration in peripheral vascular reactivity and/or baroreflex sensitivity, vascular reactivity to phenylephrine and vasopressin was assessed in renal, mesenteric, and hindquarter vascular beds using pulsed Doppler flow probes. Captopril was infused into the jugular vein or lateral ventricle of male SHR and Wistar-Kyoto (WKY) rats for 4 weeks (osmotic mini pump, 1.25 micrograms/0.5 microliter/hr). Control SHR or WKY received intracerebroventricular infusions of vehicle. Four weeks of captopril decreased arterial pressure in both SHR and WKY. In response to phenylephrine and vasopressin, SHR and WKY treated with intracerebroventricular captopril showed significantly attenuated increases in arterial pressure and vascular resistance in comparison to either vehicle-treated rats or rats receiving intravenous captopril. Reflex de...Continue Reading

References

Oct 1, 1976·The American Journal of Physiology·K Shiono, H Sokabe
Jul 1, 1982·Hypertension·J A Weyhenmeyer, M I Phillips

❮ Previous
Next ❯

Citations

Feb 1, 1991·Cardiovascular Drugs and Therapy·D GantenR E Lang
Nov 15, 1984·Biochemical Pharmacology·D GantenT Unger
Apr 25, 1990·European Journal of Pharmacology·H OoboshiM Fujishima
Jun 15, 1992·Journal of the Autonomic Nervous System·L T JablonskisP R Howe
Aug 23, 1986·Lancet·M J Brown, J Brown
Jan 8, 1999·Regulatory Peptides·M I Phillips, C Sumners
Oct 23, 1997·Journal of Cardiovascular Pharmacology·E MontemayorR D Buñag
Aug 1, 1992·Clinical and Experimental Pharmacology & Physiology·G A Head, M A Adams
Sep 1, 1995·Clinical and Experimental Pharmacology & Physiology·K TsudaM Goldstein
Mar 24, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Josef ZichaJaroslav Kunes
Nov 27, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Marcus BaumannJo G R De Mey
Oct 17, 2012·Amino Acids·Sanya Roysommuti, J Michael Wyss
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·K H Berecek, D N Shier
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·K TakedaH Ijichi
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·K H BerecekB H Swords
Feb 25, 2014·Research in Veterinary Science·Chayanon ChompoosanWinai Chansaisakorn
Oct 8, 1992·The American Journal of Cardiology·M A LeeD Ganten
Feb 11, 2004·Progress in Biophysics and Molecular Biology·Shereeni J VeerasinghamMohan K Raizada
Feb 1, 1988·Hypertension·K M WilsonK H Berecek
Feb 1, 1988·Hypertension·M J Campagnole-SantosC M Ferrario
Mar 1, 1996·Hypertension·D B AverillC M Ferrario
Jun 1, 1989·Hypertension·S W ChengK H Berecek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.